questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Protéines inhibitrices de la fraction C1 du complément
C1 Inhibiteur
C1 Inhibiteur : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Déficience en C1 inhibiteur
Tests de laboratoire
Protéines du complément
Tests de laboratoire
Antécédents médicaux
Hérédité
Symptômes
5
Maladies auto-immunes
Allergies
Prévention
5
Allergies alimentaires
Réactions
Stress
Facteurs déclenchants
Traitements
5
Traitement
Médicaments anti-inflammatoires
Corticostéroïdes
Inflammation
Thérapie génique
Traitements expérimentaux
Crise aiguë
Administration de médicaments
Complications
5
Œdème laryngé
Difficultés respiratoires
Maladies auto-immunes
Risque accru
Qualité de vie
Symptômes chroniques
Surveillance médicale
Complications
Facteurs de risque
5
Facteurs de risque
Hérédité
Facteurs environnementaux
Crises
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "C1 Inhibiteur : Questions médicales les plus fréquentes",
"headline": "C1 Inhibiteur : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les C1 Inhibiteur : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-06",
"dateModified": "2025-05-01",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "C1 Inhibiteur"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Protéines inhibitrices de la fraction C1 du complément",
"url": "https://questionsmedicales.fr/mesh/D003174",
"about": {
"@type": "MedicalCondition",
"name": "Protéines inhibitrices de la fraction C1 du complément",
"code": {
"@type": "MedicalCode",
"code": "D003174",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.872.140"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "C1 Inhibiteur",
"alternateName": "Complement C1 Inhibitor Protein",
"code": {
"@type": "MedicalCode",
"code": "D050718",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Henriette Farkas",
"url": "https://questionsmedicales.fr/author/Henriette%20Farkas",
"affiliation": {
"@type": "Organization",
"name": "Department of Internal Medicine and Haematology, Hungarian Angioedema Center of Reference and Excellence, Semmelweis University, Szentkiralyi u. 46, Budapest, 1088, Hungary. farkas.henriette@med.semmelweis-univ.hu."
}
},
{
"@type": "Person",
"name": "Lilian Varga",
"url": "https://questionsmedicales.fr/author/Lilian%20Varga",
"affiliation": {
"@type": "Organization",
"name": "Department of Internal Medicine and Haematology, Hungarian Angioedema Center of Reference and Excellence, Semmelweis University, Szentkiralyi u. 46, Budapest, 1088, Hungary."
}
},
{
"@type": "Person",
"name": "Anastasios E Germenis",
"url": "https://questionsmedicales.fr/author/Anastasios%20E%20Germenis",
"affiliation": {
"@type": "Organization",
"name": "Department of Immunology and Histocompatibility, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece."
}
},
{
"@type": "Person",
"name": "Andrea Zanichelli",
"url": "https://questionsmedicales.fr/author/Andrea%20Zanichelli",
"affiliation": {
"@type": "Organization",
"name": "Department of Biomedical and Clinical Sciences Luigi Sacco, University of Milan, Via G.B. Grassi 74, 20157 Milan, Italy."
}
},
{
"@type": "Person",
"name": "Chiara Suffritti",
"url": "https://questionsmedicales.fr/author/Chiara%20Suffritti",
"affiliation": {
"@type": "Organization",
"name": "ASST-Fatebenefratelli-Sacco, Milan, Italy. chiarasuffritti@gmail.com."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "[The virtual ILD board: a pilot project].",
"datePublished": "2023-09-11",
"url": "https://questionsmedicales.fr/article/37696286",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1055/a-2113-0556"
}
},
{
"@type": "ScholarlyArticle",
"name": "A realist review of dyslexia pilot project research.",
"datePublished": "2023-06-10",
"url": "https://questionsmedicales.fr/article/37300716",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11881-023-00284-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "A Quality Improvement Pilot Project for Noise Reduction in the NICU.",
"datePublished": "2023-04-05",
"url": "https://questionsmedicales.fr/article/37018178",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/ANC.0000000000001074"
}
},
{
"@type": "ScholarlyArticle",
"name": "Suicide Attempt Aftercare in Geriatric Patients: A Pilot Project.",
"datePublished": "2022-09-28",
"url": "https://questionsmedicales.fr/article/36170052",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/01612840.2022.2127039"
}
},
{
"@type": "ScholarlyArticle",
"name": "Diagnostic Adjunct Techniques in the Assessment of Hypovolemia: A Prospective Pilot Project.",
"datePublished": "2023-09-10",
"url": "https://questionsmedicales.fr/article/37690381",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jss.2023.08.005"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines inhibitrices de la fraction C1 du complément",
"item": "https://questionsmedicales.fr/mesh/D003174"
},
{
"@type": "ListItem",
"position": 5,
"name": "C1 Inhibiteur",
"item": "https://questionsmedicales.fr/mesh/D050718"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : C1 Inhibiteur - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur C1 Inhibiteur",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-15",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur C1 Inhibiteur",
"description": "Comment diagnostiquer une déficience en C1 inhibiteur ?\nQuels tests sont utilisés pour évaluer le C1 inhibiteur ?\nQuels symptômes indiquent un problème de C1 inhibiteur ?\nLe diagnostic nécessite-t-il une consultation spécialisée ?\nPeut-on diagnostiquer par des antécédents familiaux ?",
"url": "https://questionsmedicales.fr/mesh/D050718?mesh_terms=Pilot+Projects#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur C1 Inhibiteur",
"description": "Quels sont les symptômes d'une carence en C1 inhibiteur ?\nLes symptômes varient-ils selon l'âge ?\nLes œdèmes sont-ils toujours présents ?\nY a-t-il des symptômes associés à des infections ?\nLes symptômes peuvent-ils être confondus avec d'autres maladies ?",
"url": "https://questionsmedicales.fr/mesh/D050718?mesh_terms=Pilot+Projects#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur C1 Inhibiteur",
"description": "Comment prévenir les crises d'œdème ?\nLes patients doivent-ils éviter certains aliments ?\nLe stress influence-t-il les crises ?\nDes vaccinations sont-elles recommandées ?\nLes patients doivent-ils porter un bracelet médical ?",
"url": "https://questionsmedicales.fr/mesh/D050718?mesh_terms=Pilot+Projects#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur C1 Inhibiteur",
"description": "Quels traitements sont disponibles pour la carence en C1 inhibiteur ?\nLe traitement préventif est-il nécessaire ?\nLes corticostéroïdes sont-ils efficaces ?\nY a-t-il des traitements expérimentaux ?\nComment gérer une crise aiguë ?",
"url": "https://questionsmedicales.fr/mesh/D050718?mesh_terms=Pilot+Projects#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur C1 Inhibiteur",
"description": "Quelles sont les complications possibles de la carence en C1 inhibiteur ?\nLes œdèmes peuvent-ils entraîner des complications graves ?\nY a-t-il un risque accru de maladies auto-immunes ?\nLes complications peuvent-elles affecter la qualité de vie ?\nLes complications nécessitent-elles une surveillance régulière ?",
"url": "https://questionsmedicales.fr/mesh/D050718?mesh_terms=Pilot+Projects#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur C1 Inhibiteur",
"description": "Quels sont les facteurs de risque de carence en C1 inhibiteur ?\nLes infections fréquentes sont-elles un facteur de risque ?\nLe sexe influence-t-il le risque de carence ?\nL'âge joue-t-il un rôle dans le risque ?\nLes facteurs environnementaux influencent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D050718?mesh_terms=Pilot+Projects#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une déficience en C1 inhibiteur ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un dosage sanguin du C1 inhibiteur et des tests fonctionnels sont nécessaires."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer le C1 inhibiteur ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent le dosage du C1 inhibiteur et l'évaluation de l'activité fonctionnelle."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un problème de C1 inhibiteur ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des œdèmes, des douleurs abdominales et des éruptions cutanées."
}
},
{
"@type": "Question",
"name": "Le diagnostic nécessite-t-il une consultation spécialisée ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une consultation en immunologie ou en allergologie est souvent recommandée."
}
},
{
"@type": "Question",
"name": "Peut-on diagnostiquer par des antécédents familiaux ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de symptômes similaires peuvent orienter le diagnostic."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une carence en C1 inhibiteur ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des œdèmes récurrents, des douleurs abdominales et des éruptions cutanées."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent apparaître à tout âge, mais souvent durant l'enfance ou l'adolescence."
}
},
{
"@type": "Question",
"name": "Les œdèmes sont-ils toujours présents ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les œdèmes peuvent être intermittents et ne pas se manifester constamment."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes associés à des infections ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des infections peuvent exacerber les symptômes liés à la carence en C1 inhibiteur."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils être confondus avec d'autres maladies ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent être similaires à ceux d'autres troubles allergiques ou auto-immuns."
}
},
{
"@type": "Question",
"name": "Comment prévenir les crises d'œdème ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les déclencheurs connus et suivre un traitement préventif régulier."
}
},
{
"@type": "Question",
"name": "Les patients doivent-ils éviter certains aliments ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains aliments peuvent déclencher des réactions, il est conseillé de les identifier."
}
},
{
"@type": "Question",
"name": "Le stress influence-t-il les crises ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut être un facteur déclenchant pour certaines personnes."
}
},
{
"@type": "Question",
"name": "Des vaccinations sont-elles recommandées ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les vaccinations peuvent aider à prévenir les infections qui aggravent les symptômes."
}
},
{
"@type": "Question",
"name": "Les patients doivent-ils porter un bracelet médical ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un bracelet médical peut alerter en cas d'urgence liée à la carence en C1 inhibiteur."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour la carence en C1 inhibiteur ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des concentrés de C1 inhibiteur et des médicaments anti-inflammatoires."
}
},
{
"@type": "Question",
"name": "Le traitement préventif est-il nécessaire ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un traitement préventif peut être recommandé pour éviter les crises d'œdème."
}
},
{
"@type": "Question",
"name": "Les corticostéroïdes sont-ils efficaces ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les corticostéroïdes peuvent réduire l'inflammation, mais ne traitent pas la cause sous-jacente."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements expérimentaux ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des thérapies géniques et des traitements ciblés sont en cours d'évaluation."
}
},
{
"@type": "Question",
"name": "Comment gérer une crise aiguë ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'administration rapide de C1 inhibiteur est essentielle lors d'une crise aiguë."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles de la carence en C1 inhibiteur ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des œdèmes sévères, des infections et des douleurs chroniques."
}
},
{
"@type": "Question",
"name": "Les œdèmes peuvent-ils entraîner des complications graves ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des œdèmes laryngés peuvent provoquer des difficultés respiratoires potentiellement mortelles."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque accru de maladies auto-immunes ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les patients peuvent avoir un risque accru de développer des maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles affecter la qualité de vie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes chroniques et les crises peuvent significativement altérer la qualité de vie."
}
},
{
"@type": "Question",
"name": "Les complications nécessitent-elles une surveillance régulière ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une surveillance régulière est essentielle pour gérer les complications potentielles."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque de carence en C1 inhibiteur ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux et certaines mutations génétiques augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les infections fréquentes sont-elles un facteur de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les infections récurrentes peuvent exacerber les symptômes chez les patients."
}
},
{
"@type": "Question",
"name": "Le sexe influence-t-il le risque de carence ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la carence en C1 inhibiteur est plus fréquente chez les femmes que chez les hommes."
}
},
{
"@type": "Question",
"name": "L'âge joue-t-il un rôle dans le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque peut augmenter avec l'âge, bien que les symptômes apparaissent souvent plus tôt."
}
},
{
"@type": "Question",
"name": "Les facteurs environnementaux influencent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains facteurs environnementaux peuvent déclencher des crises chez les individus sensibles."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 01/05/2025
Contenu vérifié selon les dernières recommandations médicales
8 publications dans cette catégorie
Affiliations :
Department of Internal Medicine and Haematology, Hungarian Angioedema Center of Reference and Excellence, Semmelweis University, Szentkiralyi u. 46, Budapest, 1088, Hungary. farkas.henriette@med.semmelweis-univ.hu.
4 publications dans cette catégorie
Affiliations :
Department of Internal Medicine and Haematology, Hungarian Angioedema Center of Reference and Excellence, Semmelweis University, Szentkiralyi u. 46, Budapest, 1088, Hungary.
Publications dans "C1 Inhibiteur" :
4 publications dans cette catégorie
Affiliations :
Department of Immunology and Histocompatibility, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece.
CeMIA SA, Larissa, Greece.
Publications dans "C1 Inhibiteur" :
4 publications dans cette catégorie
Affiliations :
Department of Biomedical and Clinical Sciences Luigi Sacco, University of Milan, Via G.B. Grassi 74, 20157 Milan, Italy.
Publications dans "C1 Inhibiteur" :
3 publications dans cette catégorie
Affiliations :
ASST-Fatebenefratelli-Sacco, Milan, Italy. chiarasuffritti@gmail.com.
Publications dans "C1 Inhibiteur" :
3 publications dans cette catégorie
Affiliations :
Department of Immunology and Histocompatibility, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece.
Publications dans "C1 Inhibiteur" :
3 publications dans cette catégorie
Affiliations :
CeMIA SA, Larissa, Greece.
Publications dans "C1 Inhibiteur" :
3 publications dans cette catégorie
Affiliations :
Department of Allergology, Navy Hospital, Athens, Greece.
Publications dans "C1 Inhibiteur" :
3 publications dans cette catégorie
Publications dans "C1 Inhibiteur" :
3 publications dans cette catégorie
Affiliations :
Department of Otorhinolaryngology, Head and Neck Surgery, Ulm University Medical Center, Ulm, Germany.
Publications dans "C1 Inhibiteur" :
3 publications dans cette catégorie
Affiliations :
Department of Otorhinolaryngology, Head and Neck Surgery, Ulm University Medical Center, Ulm, Germany.
Publications dans "C1 Inhibiteur" :
3 publications dans cette catégorie
Affiliations :
Department of Otorhinolaryngology, Head and Neck Surgery, Ulm University Medical Center, Ulm, Germany.
Publications dans "C1 Inhibiteur" :
3 publications dans cette catégorie
Affiliations :
Department of Translational Medicine, University of Naples, Via S. Pansini 5, 80131 Naples, Italy.
Publications dans "C1 Inhibiteur" :
2 publications dans cette catégorie
Affiliations :
Department of Translational Medicine, Division of Medical Protein Chemistry, Lund University, Malmö, Sweden.
Publications dans "C1 Inhibiteur" :
2 publications dans cette catégorie
Affiliations :
Sanquin Diagnostic Services, Amsterdam, The Netherlands.
Publications dans "C1 Inhibiteur" :
2 publications dans cette catégorie
Affiliations :
Department of Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam University Medical Centre, Amsterdam Infection and Immunity Institute, Amsterdam, The Netherlands.
Department of Pediatric Immunology, Rheumatology, and Infectious Diseases, Emma Children's Hospital, Amsterdam University Medical Center, Amsterdam, The Netherlands.
Publications dans "C1 Inhibiteur" :
2 publications dans cette catégorie
Affiliations :
Department of Internal Medicine and Haematology, Hungarian Angioedema Center of Reference and Excellence, Semmelweis University, Szentkiralyi u. 46, Budapest, 1088, Hungary.
Publications dans "C1 Inhibiteur" :
2 publications dans cette catégorie
Affiliations :
Department of Internal Medicine and Haematology, Hungarian Angioedema Center of Reference and Excellence, Semmelweis University, Szentkiralyi u. 46, Budapest, 1088, Hungary.
Publications dans "C1 Inhibiteur" :
2 publications dans cette catégorie
Affiliations :
Department of Internal Medicine and Haematology, Semmelweis University, Budapest, Hungary.
Publications dans "C1 Inhibiteur" :
2 publications dans cette catégorie
Affiliations :
Department of Pediatrics, Eastern Virginia Medical School, 700 West Olney Road, Norfolk, VA 23507, USA.
Children's Specialty Group, 811 Redgate Avenue, Norfolk, VA 23507, USA.
Children's Hospital of the King's Daughters, 601 Children's Lane, Norfolk, VA 23507, USA.
Department of Microbiology and Molecular Cell Biology, Eastern Virginia Medical School, 700 West Olney Road, Norfolk, VA 23507-1696, USA.
Publications dans "C1 Inhibiteur" :
Interstitial lung diseases are associated with high morbitity and mortality. Rapid diagnosis in a qualified center is necessary in order to provide the best possible treatment. However, geographic dis...
We conducted a realist review of state-authorized dyslexia pilot projects to understand how they have been implemented and evaluated, and the extent to which they adhere to best practice recommendatio...
Increased noxious noise leads to adverse short-term and long-term effects on the growing neonate. The American Academy of Pediatrics recommends maintaining a noise level of less than 45 decibels (dBA)...
The purpose of this pilot project was to reduce the average noise levels by 39% at the end of an 11-week period....
The location of the project was in a large, high-acuity level IV open-pod layout NICU that consisted of 4 pods, one of which was cardiac-focused. The average baseline noise level in the cardiac pod wa...
At the end of the project, noise levels decreased from 62.6 dBA to 54 dBA, a 13.7% reduction....
At the end of this pilot project it was noted that: Online modules were the best way to educate staff. Parents should be included in the implementation of quality improvement. Healthcare providers nee...
Hospitalized patients after suicide attempts gave informed consent to a postvention project after discharge. A continuous caregiver contacted the subjects monthly by phone for a period of 1 year. In c...
Measuring the hypovolemic resuscitation end point remains a critical care challenge. Our project compared clinical hypovolemia (CH) with three diagnostic adjuncts: 1) noninvasive cardiac output monito...
Adult trauma/surgical intensive care unit patients were prospectively screened for suspected hypovolemia after acute resuscitation, excluding patients with burns, known heart failure, or severe liver/...
44 patients (62% male, median age 60) yielded 65 measures. Positive agreement with CH was 47% for NICOM, 37% for US-IVC and 10% for US-C. None of the three adjuncts correlated with CH (κ -0.045 to 0.0...
None of the adjunct measurements correlated with CH or each other, highlighting that fluid status assessment remains challenging in critical care. US should assess for right ventricular dysfunction pr...
People living with chronic disease should ideally engage with community-based exercise services following hospital-based rehabilitation. However, transition from hospital to community exercise setting...
The aims of this study were to develop and explore the feasibility of a pilot exercise referral pathway between an acute hospital and community gyms for patients with chronic health conditions and to ...
A stakeholder-informed exercise referral pathway was developed and offered to patients following completion of a hospital-based exercise programme for a chronic health condition. The pathway was evalu...
Forty-nine people living with chronic conditions (mean age 72 ± 7.8 years) participated (recruitment rate 59%). The average number of community gym visits over 4 months was 17.4 (range 0-51). Twenty-n...
A structured exercise referral pathway to support exercise transition between hospital and community settings in populations with chronic health conditions appears feasible. Participants reported high...
This manuscript offers findings from a pilot project which prepares nursing students for embodied professional practice through the lens of ethics. Four undergraduate nursing students were mentored by...
Chlamydia disproportionately affects individuals aged 15-24 years. A lack of chlamydia knowledge in this high-risk group likely contributes to decreased testing, but interventions to increase chlamydi...
A pre- and post-test design was used to evaluate participant knowledge of chlamydia before and after completing a nurse-developed web-based education intervention designed for university students....
Forty-seven undergraduate students at one U.S. university participated. A focus group and scientific evidence informed the development of the web-based education....
Participants had a significant increase in chlamydia knowledge after completing the online educational intervention (M = 8.0, SD = 0.000) compared to baseline (M = 6.5, SD = 1.5), t(33) = -5.821, p < ...
In the twenty-first century, health systems have to cope with the challenges posed by their rapidly changing environment. Among these changes, the emergence of digital health solutions is an opportuni...
This study is based on a survey of the dental care provided by three units (Oral Medicine, Periodontology, Orthodontics) of the Department of Community Dentistry, Semmelweis University, Budapest. Duri...
According to our findings, teledentistry has the potential to shorten the visit with an average of 5-10 min per patient, which adds up to 58-116 work hours in a year. If the pilot was rolled out to al...
The rapid development of digital health technologies coupled with the evolving task distribution between health professionals have a great potential to improve health system performance in pursuit of ...
Obesity is a chronic, multifactorial disease which is linked to a number of adverse endocrinological and metabolic conditions. Currently, bariatric surgery is one of the most effective treatments for ...